pharma · Anorectal Disorder · Localized Primary Osteoarthritis of Both Hips (Diagnosis)
Chia Tai Tianqing
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Chia Tai Tianqing trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Lianyungang, CN
- Employees
- 366
- Programs
- 11
- Drugs
- 15
- Patents
- 0
Chia Tai Tianqing clinical trials
Registry index of 11 ClinicalTrials.gov studies linked to Chia Tai Tianqing programs — each row shows trial ID, program name, phase, status, and indication.
Chia Tai Tianqing trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Chia Tai Tianqing.
-
Topiramate — Approved
Clinical update -
Lidocaine spray — Phase 3
Clinical update -
Lidocaine spray — Phase 3
Clinical update -
Hepatitis B vaccine — Approved
Clinical update -
Gum chewing — Phase 3
Clinical update -
Triferdine — Unknown
Clinical update -
Mevac-A vaccine — Phase 3
Clinical update -
Dexamethasone — Approved
Clinical update